Sofie July - Seeking Alpha 'Sofie July' Tag RSS Syndication from SeekingAlpha.com SeekingAlpha.com http://seekingalpha.com/author/sofie-july Potash Corp: Dynamics of Supply and Demand Drive Earnings Growth http://seekingalpha.com/article/89127-potash-corp-dynamics-of-supply-and-demand-drive-earnings-growth?source=feed 89127 The stock of Potash Corp. (POT) has experienced a huge sell-off lately due to decline of agriculture commodities prices, profit taking, concerns on the possible change of policy on ethanol after the election, etc. 

Yet I think many investors overreacted to the situation.  Please see my analysis below.

]]> Tue, 05 Aug 2008 08:06:41 -0400 Sofie July The stock of Potash Corp. (POT) has experienced a huge sell-off lately due to decline of agriculture commodities prices, profit taking, concerns on the possible change of policy on ethanol after the election, etc. 

Yet I think many investors overreacted to the situation.  Please see my analysis below.


Complete Story »]]> POT Sofie July Gilead Sciences: Industry Landscape, Strong Growth Make It a Buy http://seekingalpha.com/article/85869-gilead-sciences-industry-landscape-strong-growth-make-it-a-buy?source=feed 85869 Originally written on May 7, 2008

Gilead Sciences (GILD) is one of the leading biopharmaceutical companies, providing innovative therapeutics in areas of unmet medical needs. With the mission to advance the care of patients suffering from life-threatening diseases, Gilead discovers, develops and commercializes therapeutics solutions for patients inflicted with HIV, hepatitis B, fungal infection, and pulmonary arterial hypertension [PAH]. It is the dominant leader in the treatment of HIV patients, and has gradually expanded its product portfolio and new product pipeline into other area.

]]> Sun, 20 Jul 2008 03:03:09 -0400 Sofie July Originally written on May 7, 2008

Gilead Sciences (GILD) is one of the leading biopharmaceutical companies, providing innovative therapeutics in areas of unmet medical needs. With the mission to advance the care of patients suffering from life-threatening diseases, Gilead discovers, develops and commercializes therapeutics solutions for patients inflicted with HIV, hepatitis B, fungal infection, and pulmonary arterial hypertension [PAH]. It is the dominant leader in the treatment of HIV patients, and has gradually expanded its product portfolio and new product pipeline into other area.


Complete Story »]]> GILD Sofie July